Previous 10 | Next 10 |
DiaMedica Therapeutics Inc. (DMAC) Q2 2022 Earnings Conference Call August 11, 2022, 08:00 AM ET Company Participants Rick Pauls - President and Chief Executive Officer Kirsten Gruis - Chief Medical Officer Scott Kellen - Chief Financial Officer Conference ...
DiaMedica Therapeutics press release ( NASDAQ: DMAC ): Q2 GAAP EPS of -$0.13 beats by $0.05 . For further details see: DiaMedica Therapeutics GAAP EPS of -$0.13 beats by $0.05
Conference Call and Webcast August 11 at 8:00 am Eastern Time / 7:00 am Central Time Company Confident in Plan to Resolve Issues that Led to Clinical Hold of Phase 2/3 ReMEDy2 Trial Proposal to Resume Trial Will be Submitted to FDA in September ...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that its second quarter 2022 financial results will be released after the markets close on Wednes...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that the company’s management team will be participating in one-on-one meetings at the upc...
Toronto, Ontario--(Newsfile Corp. - July 21, 2022) - On July 8, 2022, Thomas Von Koch (the " Acquiror "), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an aggregate of 304,827 common shares (the " Purchased Shares ") of Di...
Toronto, Ontario--(Newsfile Corp. - July 21, 2022) - Thomas Von Koch (the " Acquiror "), c/o EQT Partners AB, Box 16509, 103 27 Stockholm, Sweden, acquired indirect ownership, through TomEnterprise AB, of an aggregate of 304,827 common shares (the " Purchased Shares ") of DiaMedica Therapeut...
Chinese automaker Chijet Motor Company plans to go public through a merger with SPAC Deep Medicine Acquisition Corp. ( NASDAQ: DMAQ ) that pegs the implied enterprise value of the combined company at around $2.55B. The deal, which is slated to close in Q4, is expected to g...
Gainers: Grove Collaborative ( GROV ) +80% . Faraday Future Intelligent Electric ( FFIE ) +30% . Bed Bath & Beyond ( BBBY ) +27% . Dakota Gold ( DC ) +21% . Bolt Biotherapeutics ( BOLT ) +20% . Miromatrix Medical ( MIRO...
Gainers: Longeveron ( LGVN ) +16% . Adverum Biotechnologies ( ADVM ) +13% . 89bio ( ETNB ) +12% . Mainz Biomed ( MYNZ ) +11% . Shineco ( SISI ) +8% . Losers: DiaMedica Therapeutics ( DMAC ) -41% . Cytom...
News, Short Squeeze, Breakout and More Instantly...
DiaMedica Therapeutics Inc. Company Name:
DMAC Stock Symbol:
NASDAQ Market:
DiaMedica Therapeutics Inc. Website:
Company to Host Preeclampsia Key Opinion Leader Event July 29, 2024 at 10 AM Eastern / 9 AM Central White Paper: The Potential of DM199 to Treat Preeclampsia DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel trea...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its previously announced $11.8 million private placement to accredited investors. The Company sold approximatel...
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 73.0% to $0.4585 on volume of 640,087,036 shares Ocean Power Technologies Inc. (OPTT) rose 34.9% to $0.1812 on volume of 396,326,565 shares NVIDIA Corporation (NVDA) rose 0.2% to $1...